BNET Industries

SuperGen Inc.

(SUPG) is in the Pharma Industry

Market Cap:$165.9M
Last Fiscal Year Sales:$22.9M
  • Public
  • US
Dow Jones Description

SuperGen, Inc. is committed to alleviating human suffering through the development of novel therapeutics to treat and cure life-threatening diseases. To this end, we have amassed a talented team of scientists with deep expertise to act as the engine to our drug development process. SuperGen's team includes experts in rational and fragment-based drug design, genetic model systems, small molecule drug development, and clinical trial design and execution. This enables a seamless transition between pre-clinical and clinical development, with a process aptly named CLIMB . CLIMB promises to change the current paradigm of drug discovery, by reducing the time and cost required to move from target validation to lead identification and IND-enabling studies. Using CLIMB , SuperGen intends to produce two IND-ready clinical candidates each year. The first of these candidates, MP470 and MP529, are poised for entry into clinical trials in 2007. SuperGen boasts a development pipeline of several promising compound classes at various stages of development with good drug like properties, ensuring a steady flow of novel therapeutics into the clinic.

Number of Employees 86
Contact Information

4140 Dublin Blvd Ste 200

Dublin, California 94568-7757

supergen.com

(925) 560-0100

NAICS Code Pharmaceutical Preparation Manufacturing: 325412

Recent Events

  • Bay Biz Buzz: Outlook better for chip sector

    10/27/09 - Financial Announcement - View Story

  • Early-Market Movers: SuperGen, PrivateBancorp

    10/26/09 - Joint Venture / Alliance - View Story

  • SuperGen receiving $5 million in Glaxo deal

    10/26/09 - New Investment - View Story

  • This Week in Biotech: More Treats than Tricks

    11/01/09 - Joint Venture / Alliance - View Story

  • David Bearss Leaving SuperGen, Retained as an Advisory Board Member and Consultant

    9/23/09 - Mgmt. Change Leaving - Technology - View Story

  • SuperGen names new chief medical officer

    7/22/09 - Mgmt. Change Entering - Other - View Story

News & Analysis

supergen inc. - All News and Analysis

advertisement
     SUPG $2.76 -0.03 (-1.08% )
Intraday | 3 Month | 6 Month | 1 Year
Average Volume 238,887
Shares Outstanding 60.14M
Market Cap 166.0M
Year High 3.3
Year Low 1.54
Earnings Per Share -0.01
P/E Ratio -276.00
Dividend N/A
Yield N/A
IndustryTop Rated
advertisement
Click Here